share_log
Breakings ·  Jun 25 20:24
Keros Therapeutics Inc : Oppenheimer Initiates Coverage With Outperform Rating; Target Price $102
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment